1. Conformation-Based Design and Synthesis of Apratoxin A Mimetics Modified at the α,β-Unsaturated Thiazoline Moiety
    Yuichi Onda et al, 2017, Journal of Medicinal Chemistry CrossRef
  2. Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation
    Yu-Jin Wang et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  3. TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
    Hiroki Irie et al, 2019, Molecular Cancer Therapeutics CrossRef
  4. In vitro cytotoxicity and docking study of novel symmetric and asymmetric dihydropyridines and pyridines as EGFR tyrosine kinase inhibitors
    Basem Mansour et al, 2022, Chemical Biology & Drug Design CrossRef
  5. Cell Surface Markers and their Targeted Drugs in Breast Cancer
    Tianyun Wang et al, 2022, Current Protein & Peptide Science CrossRef
  6. Characteristics of clinical trials for non-small cell lung cancer therapeutic vaccines registered on ClinicalTrials.gov
    Wenyue Gu et al, 2022, Frontiers in Immunology CrossRef
  7. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
    Nobuhiko Takahashi et al, 2019, Cells CrossRef
  8. TAS2940, a novel brain‐penetrable pan‐ERBB inhibitor, for tumors with HER2 and EGFR aberrations
    Kei Oguchi et al, 2023, Cancer Science CrossRef
  9. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
    Alessia Belloni et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  10. Total Synthesis and Structural Revision of Cyclotetrapeptide Asperterrestide A
    Kosuke Ohsawa et al, 2019, The Journal of Organic Chemistry CrossRef
  11. Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis
    Meng Wang et al, 2018, Oncology Letters CrossRef
  12. Tupistra chinensis a traditional Chinese plant suppresses tumor growth and metastasis in vitro against ER positive and triple negative breast cancer
    Adyasa Samantaray et al, 2024, Pharmacological Research - Modern Chinese Medicine CrossRef
  13. Lung cancer organoids: models for preclinical research and precision medicine
    Yajing Liu et al, 2023, Frontiers in Oncology CrossRef